P. Benhamou, B. Catargi, B. Delenne, B. Guerci, H. Hanaire et al., Realtime continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE, Diabetes Metab, vol.38, pp.67-83, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01930684

D. Raccah, V. Sulmont, Y. Reznik, B. Guerci, R. E. Hanaire et al., Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care, vol.32, pp.2245-50, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00448802

S. Picard, H. Hanaire, S. Baillot-rudoni, E. Gilbert-bonnemaison, D. Not et al., Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study, Diabetes Technol Ther, vol.18, issue.3, pp.127-162, 2016.

P. Choudhary, B. S. Olsen, I. Conget, J. B. Welsh, L. Vorrink et al., Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management, Diabetes Technol Ther, vol.18, issue.5, pp.288-91, 2016.

M. B. Abraham, J. A. Nicholas, T. T. Ly, H. C. Roby, N. Paramalingam et al., Safety and efficacy of the predictive low glucose management system in the prevention of hypoglycaemia: protocol for randomised controlled home trial to evaluate the Suspend before low function, BMJ Open, vol.6, issue.4, p.11589, 2016.

D. M. Nathan, B. Zinman, P. A. Cleary, J. Backlund, and S. Genuth, Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications, vol.169, pp.1307-1323, 1983.

, The Diabetes Control and Complications Trial Research Group, Hypoglycemia in the Diabetes Control and Complications Trial, vol.46, pp.271-86, 1997.

T. Battelino, I. Conget, B. Olsen, I. Schütz-fuhrmann, E. Hommel et al., The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial, Diabetologia, vol.55, issue.12, pp.3155-62, 2012.

M. Brod, M. Hammer, T. Christensen, S. Lessard, and D. M. Bushnell, Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device), Health Qual Life Outcomes, vol.7, p.83, 2009.

M. Brod, T. Christensen, M. Hammer, A. K. Busk, and D. M. Bushnell, Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures. Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.20, pp.1513-1521, 2011.

J. Riveline, P. Schaepelynck, L. Chaillous, R. E. Sola-gazagnes, A. Penfornis et al., Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study. Diabetes Care, vol.35, pp.965-71, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01930701

D. C. Klonoff, R. M. Bergenstal, S. K. Garg, B. W. Bode, M. Meredith et al., ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia, J Diabetes Sci Technol, vol.7, issue.4, pp.1005-1015, 2013.

R. M. Bergenstal, D. C. Klonoff, S. K. Garg, B. W. Bode, M. Meredith et al.,

, Threshold-based insulin-pump interruption for reduction of hypoglycemia, N Engl J Med, vol.369, issue.3, pp.224-256, 2013.

T. Battelino, M. Phillip, N. Bratina, R. Nimri, P. Oskarsson et al., Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care, vol.34, pp.795-800, 2011.

S. Roze, J. Smith-palmer, W. Valentine, V. Payet, S. De-portu et al., CostEffectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France, Diabetes Technol Ther, vol.18, issue.2, pp.75-84, 2016.

A. J. Palmer, R. S. Valentine, W. J. Minshall, M. E. Foos, V. Lurati et al., Validation of the CORE Diabetes Model against epidemiological and clinical studies, Curr Med Res Opin, issue.1, pp.27-40, 1920.

A. J. Palmer, R. S. Valentine, W. J. Minshall, M. E. Foos, V. Lurati et al., The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making, Curr Med Res Opin, issue.1, pp.5-26, 1920.

M. A. Quemerais, M. Doron, F. Dutrech, V. Melki, S. Franc et al., Preliminary evaluation of a new semi-closed-loop insulin therapy system over the prandial period in adult patients with type 1 diabetes: the WP6.0 Diabeloop study, J Diabetes Sci Technol, vol.8, issue.6, pp.1177-84, 2014.

, Lorsque la glycémie est en-dessous de l'objectif : 2. Lorsque la glycémie est à l'objectif

J. A. Todd, Etiology of type 1 diabetes, Immunity. 23 avr, vol.32, issue.4, pp.457-67, 2010.

, Institut de veille sanitaire (France). Prévalence et incidence du diabète, et mortalité liée au diabète en France: synthèse épidémiologique, User S. IDF diabetes atlas-Across the globe, 2010.

, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N Engl J Med, vol.329, issue.14, pp.977-86, 1993.

V. Lassmann-vague, S. Clavel, B. Guerci, H. Hanaire, R. Leroy et al., When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM), Diabetes Metab. févr, vol.36, issue.1, pp.79-85, 2009.
DOI : 10.1016/j.diabet.2009.09.002

URL : https://hal.archives-ouvertes.fr/hal-00482959

J. Weissberg-benchell, J. Antisdel-lomaglio, and R. Seshadri, Insulin pump therapy: a metaanalysis, Diabetes Care. avr, vol.26, issue.4, pp.1079-87, 2003.

J. C. Pickup and A. J. Sutton, Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion, Diabet Med J Br Diabet Assoc. juill, vol.25, issue.7, pp.765-74, 2008.

B. Guerci, P. Böhme, C. Halter, and C. Bourgeois, Capteurs de glucose et mesure continue du glucose: Glucose sensor and continuous glucose measurement, Médecine Mal Métaboliques. mars, vol.4, issue.2, pp.157-68, 2010.
DOI : 10.1016/s1957-2557(10)70032-8

J. Riveline, Is continuous glucose monitoring (CGM) for everyone? To whom should CGM be prescribed and how?, Diabetes Metab. déc, vol.37, issue.4, pp.80-84, 2011.
DOI : 10.1016/s1262-3636(11)70971-5

P. Lecomte, I. Romon, S. Fosse, D. Simon, and A. Fagot-campagna, Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study, Diabetes Metab. juin, vol.34, issue.3, pp.219-245, 2001.

J. C. Pickup, S. C. Freeman, and A. J. Sutton, Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: metaanalysis of randomised controlled trials using individual patient data, BMJ, vol.343, p.3805, 2011.

J. Riveline, P. Schaepelynck, L. Chaillous, R. E. Sola-gazagnes, A. Penfornis et al., Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study, Diabetes Care. mai, vol.35, issue.5, pp.965-71, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01930701

R. M. Bergenstal, W. V. Tamborlane, A. Ahmann, J. B. Buse, G. Dailey et al., Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes, N Engl J Med. 22 juill, vol.363, issue.4, pp.311-331, 2010.

R. W. Beck, B. Buckingham, K. Miller, H. Wolpert, and D. Xing, Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care, Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, vol.32, pp.1947-53, 2009.

I. B. Hirsch, J. Abelseth, B. W. Bode, J. S. Fischer, F. R. Kaufman et al., Sensoraugmented insulin pump therapy: results of the first randomized treat-to-target study, Diabetes Technol Ther. oct, vol.10, issue.5, pp.377-83, 2008.

D. Raccah, V. Sulmont, Y. Reznik, B. Guerci, R. E. Hanaire et al., Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study, Diabetes Care. déc, vol.32, issue.12, pp.2245-50, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00448802

D. Deiss, J. Bolinder, J. Riveline, T. Battelino, E. Bosi et al., Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring, Diabetes Care. déc, vol.29, issue.12, pp.2730-2732, 2006.
DOI : 10.2337/dc06-1134

URL : http://care.diabetesjournals.org/content/diacare/29/12/2730.full.pdf

W. V. Tamborlane, R. W. Beck, B. W. Bode, B. Buckingham, and H. P. Chase, Continuous glucose monitoring and intensive treatment of type 1 diabetes, Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, vol.359, pp.1464-76, 2008.

J. Hermanides, K. Nørgaard, D. Bruttomesso, C. Mathieu, A. Frid et al.,

, Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial, Diabet Med J Br Diabet Assoc, vol.28, issue.10, pp.1158-67, 2011.

S. Schmidt and K. Nørgaard, Sensor-augmented pump therapy at 36 months, Diabetes Technol Ther. déc, vol.14, issue.12, pp.1174-1181, 2012.
DOI : 10.1089/dia.2012.0148

T. Battelino, I. Conget, B. Olsen, I. Schütz-fuhrmann, E. Hommel et al., The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial, Diabetologia. déc, vol.55, issue.12, pp.3155-62, 2012.

R. W. Beck, I. B. Hirsch, L. Laffel, W. V. Tamborlane, and B. W. Bode, The effect of continuous glucose monitoring in well-controlled type 1 diabetes, Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, vol.32, pp.1378-83, 2009.

D. C. Klonoff, R. M. Bergenstal, S. K. Garg, B. W. Bode, M. Meredith et al., ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia, J Diabetes Sci Technol. juill, vol.7, issue.4, pp.1005-1015, 2013.

R. M. Bergenstal, D. C. Klonoff, S. K. Garg, B. W. Bode, M. Meredith et al.,

, Threshold-based insulin-pump interruption for reduction of hypoglycemia, N Engl J Med. 18 juill, vol.369, issue.3, pp.224-256, 2013.

T. Battelino, M. Phillip, N. Bratina, R. Nimri, P. Oskarsson et al., Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes, Diabetes Care. avr, vol.34, issue.4, pp.795-800, 2011.

P. Choudhary, S. Ramasamy, L. Green, G. Gallen, S. Pender et al., RealTime Continuous Glucose Monitoring Significantly Reduces Severe Hypoglycemia in Hypoglycemia-Unaware Patients With Type 1 Diabetes, Diabetes Care. déc, vol.36, issue.12, pp.4160-4162, 2013.

P. Benhamou, B. Catargi, B. Delenne, B. Guerci, H. Hanaire et al., Realtime continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE, Diabetes Metab. juill, vol.38, pp.67-83, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01930684

, Standards of Medical Care in Diabetes-2016: Summary of Revisions, Diabetes Care. janv, vol.39, issue.1, pp.4-5, 2016.

P. Choudhary, J. Shin, Y. Wang, M. L. Evans, P. J. Hammond et al., Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk, Diabetes Care. sept, vol.34, issue.9, pp.2023-2028, 2011.

T. T. Ly, J. A. Nicholas, A. Retterath, E. M. Lim, E. A. Davis et al., Effect of sensoraugmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial, JAMA. 25 sept, vol.310, issue.12, pp.1240-1247, 2013.

J. L. Sherr, P. Collazo, M. Cengiz, E. Michaud, C. Carria et al., Safety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose, Diabetes Care, vol.37, issue.3, pp.773-782, 2014.

P. Choudhary, B. S. Olsen, I. Conget, J. B. Welsh, L. Vorrink et al., Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management, Diabetes Technol Ther. mai, vol.18, issue.5, pp.288-91, 2016.

M. B. Abraham, J. A. Nicholas, T. T. Ly, H. C. Roby, N. Paramalingam et al., Safety and efficacy of the predictive low glucose management system in the prevention of hypoglycaemia: protocol for randomised controlled home trial to evaluate the Suspend before low function, BMJ Open, vol.6, issue.4, p.11589, 2016.

W. D. Willis, J. I. Diago-cabezudo, A. Madec-hily, and A. Aslam, Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey, Expert Rev Pharmacoecon Outcomes Res. févr, vol.13, issue.1, pp.123-153, 2013.

E. Torreton, T. Vandebrouck, P. Emiel, and B. Detournay, Cost of Inpatient Management of Hypoglycaemia in France. Value Health, vol.16, p.436, 2013.

K. Chevreul, B. Brigham, K. Bouché, and C. , The burden and treatment of diabetes in France, Glob Health, vol.10, p.6, 2014.

A. J. Palmer, R. S. Valentine, W. J. Minshall, M. E. Foos, V. Lurati et al., The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making, Curr Med Res Opin. août, vol.20, issue.1, pp.5-26, 2004.

M. Henriksson, R. Jindal, C. Sternhufvud, K. Bergenheim, E. Sörstadius et al., A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus, PharmacoEconomics. juin, vol.34, issue.6, pp.569-85, 2016.

A. J. Palmer, R. S. Valentine, W. J. Minshall, M. E. Foos, V. Lurati et al., Validation of the CORE Diabetes Model against epidemiological and clinical studies, Curr Med Res Opin. août, vol.20, issue.1, pp.27-40, 2004.

P. Mcewan, V. Foos, J. L. Palmer, M. Lamotte, A. Lloyd et al., Validation of the IMS CORE Diabetes Model, Value Health J Int Soc Pharmacoeconomics Outcomes Res. sept, vol.17, issue.6, pp.714-738, 2014.

S. Roze, R. Saunders, A. Brandt, S. De-portu, N. L. Papo et al., Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes, Diabet Med. 1 mai, vol.32, issue.5, pp.618-644, 2015.

S. Roze, J. Smith-palmer, W. Valentine, V. Payet, S. De-portu et al., CostEffectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France, Diabetes Technol Ther. févr, vol.18, issue.2, pp.75-84, 2016.

S. Picard, H. Hanaire, S. Baillot-rudoni, E. Gilbert-bonnemaison, D. Not et al., Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study, Diabetes Technol Ther. mars, vol.18, issue.3, pp.127-162, 2016.

T. T. Ly, J. A. Nicholas, A. Retterath, E. A. Davis, and T. W. Jones, Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy, Diabetes Care. juill, vol.35, issue.7, pp.1462-1467, 2012.

M. Brod, T. Christensen, M. Hammer, A. K. Busk, and D. M. Bushnell, Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures, Qual Life Res, vol.20, issue.9, pp.1513-1521, 2011.

M. Brod, M. Hammer, T. Christensen, S. Lessard, and D. M. Bushnell, Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device), Health Qual Life Outcomes. 9 sept, vol.7, p.83, 2009.

G. M. Steil, K. Rebrin, C. Darwin, F. Hariri, and M. F. Saad, Feasibility of automating insulin delivery for the treatment of type 1 diabetes, Diabetes. déc, vol.55, issue.12, pp.3344-50, 2006.

D. Elleri, D. B. Dunger, and R. Hovorka, Closed-loop insulin delivery for treatment of type 1 diabetes, BMC Med, vol.9, p.120, 2011.

M. A. Quemerais, M. Doron, F. Dutrech, V. Melki, S. Franc et al., Preliminary evaluation of a new semi-closed-loop insulin therapy system over the prandial period in adult patients with type 1 diabetes: the WP6.0 Diabeloop study, J Diabetes Sci Technol, vol.8, issue.6, 2014.